Difficulty: Medium
Average Score: 83%
Practice
An infant with marked cyanotic heart defect with decreased pulmonary vascularity should be treated with:
Correct answer
B
Rationale
In the case of an infant with marked cyanotic heart defect and decreased pulmonary vascularity, the correct treatment option is Prostaglandin E1 (Option B). Prostaglandin E1 is used to maintain the patency of the ductus arteriosus in such cases, allowing for improved mixing of oxygenated and deoxygenated blood, which can help alleviate cyanosis and improve oxygenation.
Epinephrine (Option A) is a medication used in cases of cardiac arrest or severe allergic reactions and would not be the primary treatment for this specific cardiac condition. Dopamine (Option C) is a medication used to support blood pressure and cardiac output in cases of hypotension, which may not directly address the underlying cyanotic heart defect. Digoxin (Option D) is a medication used in some cases of heart failure but is not the first-line treatment for a marked cyanotic heart defect with decreased pulmonary vascularity.
In an educational context, understanding the rationale behind the correct treatment is crucial for pediatric nurses caring for infants with complex cardiac conditions. Knowing the appropriate medications and their mechanisms of action can significantly impact patient outcomes and ensure safe and effective care delivery. This knowledge also highlights the importance of thorough assessment, accurate diagnosis, and evidence-based treatment interventions in pediatric nursing practice.
Epinephrine (Option A) is a medication used in cases of cardiac arrest or severe allergic reactions and would not be the primary treatment for this specific cardiac condition. Dopamine (Option C) is a medication used to support blood pressure and cardiac output in cases of hypotension, which may not directly address the underlying cyanotic heart defect. Digoxin (Option D) is a medication used in some cases of heart failure but is not the first-line treatment for a marked cyanotic heart defect with decreased pulmonary vascularity.
In an educational context, understanding the rationale behind the correct treatment is crucial for pediatric nurses caring for infants with complex cardiac conditions. Knowing the appropriate medications and their mechanisms of action can significantly impact patient outcomes and ensure safe and effective care delivery. This knowledge also highlights the importance of thorough assessment, accurate diagnosis, and evidence-based treatment interventions in pediatric nursing practice.